In 2021 Paris sold Ovia Health to Labcorp (LH). Paris was the CEO and founder of Ovia Health, the leading women’s health and technology company. Ovia Health's fertility, pregnancy, and parenting programs helped over 20 million families and improved obstetric and fertility care around the world for women and infants. Paris also founded and led Good Start Genetics. Good Start Genetics is a genomics technology company focused on fertility and reproductive health. Good Start Genetics was acquired by Invitae (NYSE: NVTA).
A recognized expert on entrepreneurship, Paris has lectured extensively in academic and corporate settings including Harvard, MIT and Wharton. Paris holds a bachelor’s degree from Amherst College, and an M.B.A. and M.P.A from Harvard University, where he was a Reynolds Fellow.
I am an avid cyclist and he and his wife split their time between Miami and New England to avoid cold weather at all costs and keep riding bikes year-round.
How I can help: I love working with students on digital health and healthcare businesses. I like talking about strategy, team formation, fundraising, and generally what it takes to be a founder/CEO.
Paris Wallace
CEO & Founder, NCL (National Cycling League), Former Ovia Health
Industry Expert